Related Experiment Video
Updated: Sep 26, 2026
Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
SEROLOGICAL CLEARANCE OF HBSAG IN CHRONIC HEPATITIS B: EXPERIENCE IN A UNIVERSITY HOSPITAL
Ana Gabriella Gonçalves Amorim1, Alessandra Porto de Macedo Costa1
1Universidade Federal do Maranhão, Hospital Universitário Presidente Dutra, Departamento de Hepatologia, São Luís, Maranhão, Brasil.
Background:
Chronic hepatitis B virus (HBV) infection represents a major public health problem due to its high morbidity and mortality associated with liver cirrhosis and hepatocellular carcinoma. Functional cure, characterized by serological clearance of the HBV surface antigen (HBsAg), is the main therapeutic goal, since sterilizing viral eradication is not yet feasible. HBsAg clearance rates vary widely in the literature, and understanding the factors associated with this event is crucial for optimizing patient management.
Objective:
To investigate the HBsAg clearance rate and identify the demographic, clinical, and virological factors associated with this event in a cohort of patients with chronic hepatitis B virus infection followed up at a reference center in Northeast Brazil.
Methods:
A retrospective cohort study was conducted through a review of the medical records of patients with chronic hepatitis B virus infection treated at a Hepatology Service in Northeast Brazil between January 2015 and October 2025. Clinical, demographic and laboratory variables were analyzed. Statistical analysis used tests such as Mann-Whitney for quantitative variables and Fisher's exact test for categorical variables, in addition to the construction of Kaplan-Meier curves with the Log-Rank test to evaluate HBsAg clearance. The significance level was set at P<0.05.
Results:
Of the 600 medical records screened, 299 patients were included in the analysis, 63.2% of whom were women, with a median age of 45 years. During a mean follow-up period of 5.14 years, totaling 1,538 person-years, 12 patients (4%) achieved serological clearance of HBsAg, resulting in an annual rate of 0.78%. Statistical analysis revealed significant associations between HBsAg clearance and advanced age (P=0.008) and lower HBV-DNA levels (P=0.0156).
Conclusion:
The annual rate of HBsAg serological clearance in this cohort was 0.78%. Advanced age and low viral load levels were significantly associated with functional cure. These findings enrich the knowledge about the natural history of chronic hepatitis B in the region and reaffirm the importance of viral suppression in disease control.
